ADVAGRAF
As listed in the register: ADVAGRAF 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA
0,5 mg Tacrolimus · cápsula dura de liberación prolongada
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Tacrolimus
- Made by
- Astellas Pharma Europe B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
Canada6 matching products
Netherlands17 matching products
- Prograft 0 0,5 mg · capsule, hard7 makers
- Adport 0 0,5 mg · capsule, hard2 makers
- Advagraf 0 0,5 mg · capsule met verlengde afgifte, hard
- Conferoport 0 0,5 mg · capsule met verlengde afgifte, hard
- Dailiport 0 0,5 mg · capsule met verlengde afgifte, hard
- Tacforius 0.5 mg 0.5 mg · capsule met verlengde afgifte, hard
- Tacni 0 0,5 mg · capsule, hard
- Tacrolimus CF 0 0,5 mg · capsule, hard
SwitzerlandNo exact match for this strength and form
Details
| Made by | Astellas Pharma Europe B.V. |
|---|---|
| Active substance | Tacrolimus |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 0,5 mg Tacrolimus |
| Form | cápsula dura de liberación prolongada |
| Classification | L04AD02 · Cancer treatments and immune-system medicines |
| Route | vía oral |
| Marketed | Yes, according to the register |
| Driving | The regulator flags that this medicine can affect the ability to drive. |
| Name in the register | ADVAGRAF 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA |
| Nº Registro | 07387014 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.
Other strengths and forms
5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- cápsula dura de liberación prolongada5 products
- 0,5 mg Tacrolimus
1 mg Tacrolimus2
1 mg Tacrolimus · 2 companies
- 3 mg Tacrolimus
- 5 mg Tacrolimus
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.